Refine Your Market-Entry Strategy
- Assess market potential through historic sales figures
- Evaluate buyer power with data on reimbursement segmentation
- Align distribution methods with information on where and how drugs are purchased
Gain Insights From Drug Patent Litigation
- Study failed patent challenges to develop a better strategy
- Collect competitive intelligence by examining contractual disputes
- Track litigation to anticipate early generic entry
Find and Evaluate Business Opportunities
- Assess levels of generic competition
- Use drug price ranges to evaluate price elasticity
- Determine optimal prices before launch
Global Drug Patents
- Drug Patents in 134 Countries
- Evaluate branded and generic market opportunities globally
Global Biopharmaceutical Business Intelligence
- Identify and evaluate commercial opportunities
- Branded and generic drug pipeline forecasting
- Anticipate future revenue events
- Identify API and finished drug product suppliers
Find Generic Drug Entry Opportunities
- Inform portfolio management decisions
- Sector landscaping and due diligence
- Track drugs in development and explore new indications for existing drugs
Make Better Decisions: Try a trial or see plans & pricing
You Need More Than Just Patents
DrugPatentWatch started in 2002 to answer a simple question: When do drug patents expire?
Since then, the industry has seen dramatic changes, and you need deeper insights and intelligence to support your decision-making.
We have responded and offer specialized tools to help you stay ahead of the competition:
- Which drugs present the most attractive generic entry opportunities …
- Who will be the first generic entrants?
- How can I design my patents to anticipate patent challenges?
- How can I anticipate future drug formulary budgets?
- What are the dominant sales channels for a drug?
- Which drugs have no patents and no generic competition?
-
… in my country?
… by dosage form?
… by therapeutic category?
Make Better Decisions: Try a trial or see plans & pricing
The DrugPatentWatch Design Philosophy
Anticipate the Future
Global biopharmaceutical markets face constant change. To remain competitive you need to anticipate what’s next. We understand and work together with you to help you make better decisions.
If you are expanding into new markets, looking inward for growth opportunities, or seeking to improve your current activities, DrugPatentWatch can help.
Actionable Insights, Quickly
You need to find information quickly. We know that analyzing market data can be convoluted. To help you make better decisions we bring together objective data from diverse sources to make it easier.
We provide relevant context and ensure you have the information you need at your fingertips. This helps you see opportunities and enrich your analysis, without overwhelming you with options or asking you to perform many searches.
Our sophisticated algorithms are also tailored to help you extract valuable insights. With a single click you can find answers to complex questions such as:
- Which drugs have no patents and no competitors?
- What are all the patents covering any given dosage form (e.g. injectables)?
- What is the earliest generic entry opportunity date for a drug with dozens of patents?
Modular Information With Transparent Pricing
We focus on delivering the greatest value and lowest cost by directing our attention to high-impact problems.
DrugPatentWatch originated in 2002 to answer a simple question: When do drug patents expire? Your needs evolve as the industry keeps changing. We maintain focus on product development by listening to client needs and only providing solutions aligned with our values and unique abilities.
You want easy access to relevant information. We offer modular datasets with flexible and transparent pricing. Pick the data sets you need and the subscription duration which suits you.
Our prices and options are clearly observable to ensure that you receive the information you need at a predictable price.
Objective Data, Not Opinions
We are obsessed with eliminating bias in our analyses.
We only use primary data sets—objective information direct from government sources. Our analytic methods emphasize consistency and repeatability.
When situations change our data and analysis respond accurately and immediately. This gives you confidence that the decisions you make have a solid foundation.
Engineered to Help You Make Better Decisions
Our improvements over time have come from one source: interactions with clients. Please tell us how we can help you make better decisions. You can also learn more about our customer-centric transparent pricing.
Make Better Decisions: Try a trial or see plans & pricing
DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …
Clients in 66 Countries
Serving hundreds of leading biopharmaceutical companies globally:
